Advancing Lung Cancer Screening One Text at a Time

February 16, 2026 updated by: Francisco Cartujano, MD, University of Rochester
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • New York
      • Rochester, New York, United States, 14642
        • Recruiting
        • University of Rochester Medical Center
        • Contact:
        • Principal Investigator:
          • Francisco Cartujano, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 50 to 80 years old
  • have not completed their annual screening for lung cancer
  • have a 20 pack-year smoking history
  • currently smoke or have quit within the past 15 years
  • speak English and/or Spanish
  • have a functioning cellphone number with unlimited text messaging capacity
  • be willing to complete a baseline and a follow-up (at Month 3) survey

Exclusion Criteria:

  • being up-to-date on their annual lung cancer screening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: UR Screened
A text messaging program designed to promote lung cancer screening
Behavioral: Text messaging program
A text messaging program designed to promote lung cancer screening
Active Comparator: Control group
A mailed educational material along with a flyer for the lung cancer screening program
Behavioral: Educational material
A mailed educational material along with a flyer for the lung cancer screening program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent of Participants Who Undergo Lung Cancer Screening
Time Frame: Month 3
The proportion of study participants who complete a lung cancer screening test within 3 months of study enrollment
Month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Rochester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

November 10, 2025

First Submitted That Met QC Criteria

November 10, 2025

First Posted (Actual)

November 12, 2025

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • STUDY00010975

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer Screening

Clinical Trials on Text messaging program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe